Riskpilot← Back to searchSign inGet full accessSynbio Powerlabs Oy
OYActiveY-tunnus 3278880-8Purotie 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 2022— employeeswww.synbiopowerlabs.com
Revenue 2024
EUR 23K
+1968% vs 2023
EBITDA margin
-4677.5%
-301% vs 2023
Equity ratio
-74.6%
Financial strength
Net profit 2024
EUR -1,3M
-372% vs 2023
| Revenue | EUR 23K | +1968% |
| EBITDA | EUR -1,1M | -301% |
| Net profit | EUR -1,3M | -372% |
| Total assets | EUR 2,4M | +49% |
| Equity | EUR -1,8M | -407% |
| Employees | — | — |
Legal name
Synbio Powerlabs Oy
Y-tunnus number
3278880-8
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
4. huhtikuuta 2022
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Biotekninen tutkimus ja kehittäminen. Tiedekonsultointi ja laboratoriotoiminta. Opetus- ja kurssitoiminta sekä kaikki muu laillinen liiketoiminta.
Address
Purotie 1
Phone
+3580505579155
Email
future@synbiopowerlabs.com
Website
www.synbiopowerlabs.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 1 | 23 |
| Staff expenses | −172 | −112 |
| EBITDA | −264 | −1 058 |
| Depreciation & amort. | −10 | −41 |
| EBIT | −273 | −1 099 |
| Net financials | −1 | −195 |
| Profit before tax | −274 | −1 293 |
| Tax | −0 | −0 |
| Net profit | −274 | −1 293 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 1 579 | 2 352 |
| Equity | −346 | −1 755 |
| Long-term debt | 1 629 | 2 912 |
| Short-term debt | 296 | 1 195 |
| Total debt | 1 925 | 4 107 |
EBITDA margin
-4677.5%
This company
15.8%
Market median
-29704% vs market
20232024
Equity ratio
-74.6%
This company
38.2%
Market median
-295% vs market
20232024
Return on equity
-129339000.0%
This company
18.4%
Market median
-702929448% vs market
20232024
Net profit margin
-5718.2%
This company
8.1%
Market median
-70695% vs market
20232024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20232024
Debt / equity
2.34×
This company
0.62×
Market median
-277% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
NJ Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
KC Deputy Member | Deputy Member | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Chairperson | 2023 | |
| Board of Directors | 2023 | |
| Former (4) | ||
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Synbio Powerlabs Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nina Johanna Pulkkis | Chief Executive Officer | 0 companies |
| Kati Carita Sointukangas | Deputy Member | 0 companies |
| Sanna Katariina Taskila | Board of Directors | 0 companies |
| Paola Alexandra Díaz | Board of Directors | 0 companies |
| Tuula Maarit Palmén | Board of Directors | 0 companies |
| Eelis Juho Waltter Paukku | Board of Directors | 0 companies |
| Anna-Marja Katariina Hoffrén | Board of Directors | 0 companies |
| Alejandro Carlos Antalich Raibar | Chairperson | 0 companies |
| Juan Martin Presa Lombardi | Board of Directors | 0 companies |